An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in mice

Microbiology

Volumn 142, Issue 7, 1996, Pages 1847-1853

  Oyston, Petra C F ^a   Russell, Paul ^a   Williamson, E Diane ^a   Titball, Richard W ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

aroA; Yersinia pestis

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM MUTANT; EXPRESSION VECTOR; GUINEA PIG; IMMUNE RESPONSE; MICROBIAL ATTENUATION; MORBIDITY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SEQUENCE HOMOLOGY; TIME OF DEATH; YERSINIA PESTIS;

EID: 0029888620     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/13500872-142-7-1847     Document Type: Article

References (43)

1. Alexander, J. E., Andrew, P. W., Jones, D. & Roberts, I. S. (1993). Characterization of an aromatic amino acid-dependent Listeria monocytogenes mutant: attenuation, persistence and ability to produce protective immunity in mice. Infect Immun 61, 2245-2248.
2. Bowe, F., O'Gaora, P., Maskell, D., Cafferkey, M. & Dougan, G. (1989). Virulence, persistence and immunogenicity of Yersinia enterocolitica O:8 aroA mutants. Infect Immun 57, 3234-3236.
3. Burrows, T. W. (1960). Biochemical properties of virulent and avirulent strains of bacteria: Salmonella typhosa and Pasteurella pestis. Ann NY Acad Sci 88, 1125-1135.
4. Burrows, T. W. (1963). Virulence of Pasteurella pestis and immunity to plague. In Ergebnisse der Mikrobiologie Immunitatsforschung und Experimentellen Therapie, pp. 59-113. Berlin: Springer-Verlag.
5. Burrows, T. W. & Gillet, W. A. (1971). Host specificity of Brazilian strains of Pasteurella pestis. Nature 229, 51-52.
6. Clements, J. D., Bao, J. X. & Cardenas, L. (1992). Use of attenuated bacteria as live oral vaccine vectors. In Recombinant DNA Vaccines: Rationale and Strategy, pp. 293-322. Edited by R. E. Isaacson. New York: Marcel Dekker.
7. Cowling, P. & Moss, P. (1994). Infectivity of pneumonic plague. Br Med J 309, 1369.
8. Davis, K. J., Fritz, D. L., Pitt, M. L., Welkos, S. L., Worsham, P. L. & Friedlander, A. M. (1996). Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopitheus aethiops). Arch Pathol Lab Med 120, 156-163.
9. Demidova, G. V., Goncharov, E. K. & Tynyanova, V. I. (1984). Comparison of the recognition site specificities of adenyl and cytosyl DNA methylases of Yersinia pestis EV76 dam and dcm with E. coli methylases. Biokhimiya 49, 1594-1597.
10. Dower, W. J., Miller, J. F. & Ragsdale, C. W. (1988). High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res 16, 6127-6145.
11. Drozdov, I., Anisimov, A. P., Samoilova, L V., Yezhov, I. N., Yeremin, S. A., Karlyshev, A. V., Krasilnikova, V. M. & Kravchenko, V. I. (1995). Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis. J Med Microbiol 42, 264-268.
12. Duncan, K. & Coggins, J. R. (1986). The serC-aroA operon of Escherichia coli. Biochem J 234, 49-57.
13. Dybvig, K., Hollinshead, S. K., Heath, D. G., Clewell, D. B., Sun, F. & Woodard, A. (1992). Degenerate oligonucleotide primers for enzymatic amplification of recA sequences from Gram positive bacteria and mycobacteria. J Bacteriol 174, 2729-2732.
14. Grinter, N. J. (1983). A broad-host-range cloning vector transposable to various replicons. Gene 21, 133-143.
15. Havard, H. L., Hunter, S. E. C. & Titball, R. W. (1992). Comparison of the nucleotide sequence and development of a PCR test for the epsilon toxin gene of Clostridium perfringens. FEMS Lett 97, 77-82.
16. Heesemann, J., Hantke, K., Vocke, T., Saken, E., Rakin, A., Stojiljkovic, I. & Berner, R. (1993). Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane polypeptide of 65,000 Da and pesticin sensitivity. Mol Microbiol 8, 397-408.
17. Hoiseth, S. K. & Stocker, B. A. D. (1981). Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238-239.
18. Homchampa, P., Strugnell, R. A. & Adler, B. (1992). Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of a constructed aroA mutant. Mol Microbiol 6, 3585-3593.
19. -) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect Immun 58, 303-308.
20. Leary, S. E. C., Williamson, E. D., Griffin, K. F., Russell, P., Eley, S. M. & Titball, R. W. (1995). Active immunization with recombinant V antigen from Yersinia pestis protects against plague. Infect Immun 63, 2854-2858.
21. Levine, M. M., Herrington, D., Murphy, J. R., Morris, J. G., Losonsky, G., Tall, B., Lindberg, A. A., Svenson, S., Baqar, S., Edwards, M. F. & Stocker, B. (1987). Safety, infectivity, immunogenicity and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typbi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest 79, 888-902.
22. MacFarland, W. C. & Stocker, B. A. D. (1987). Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and two strains of Salmonella typhimurium. Microb Pathog 3, 129-141.
23. Marmur, J. (1961). A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J Mol Biol 3, 208-218.
24. Marshall, J. D., Bartelloni, P. J., Cavanaugh, D. C., Kadull, P. J. & Meyer, K. F. (1974). Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine. J Infect Dis 129, S19-S25.
25. Maskell, D., Sweeny, K., O'Callaghan, D., Hormaeche, C., Liew, F. & Dougan, G. (1987). Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the secretory and systemic immune systems. Microb Pathog 2, 211-221.
26. McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasava, M. & Kiyono, H. (1992). The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10, 75-88.
27. Meyer, K. F. (1970). Effectiveness of live or killed plague vaccines in man. Bull WHO 42, 653-666.
28. Meyer, K. F., Cavanaugh, D. C., Bartelloni, P. J. & Marshall, J. D. (1974a). Plague immunization. I. Past and present trends. J Infect Dis S129, S13-S18.
29. Meyer, K. F., Hightower, J. A. & McCrumb, F. R. (1974b). Plague immunization. VI. Vaccination with the fraction 1 antigen of Yersinia pestis. J Infect Dis S129, S41-S45.
30. Meyer, K. F., Smith, G., Foster, L. E., Brookman, M. & Sung, M. (1974c). Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs. J Infect Dis S129, S85-S120.
31. Miller, V. & Mekalanos, J. (1988). A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170, 2575-2583.
32. Motin, V. L., Nakajima, R., Smirnov, G. B. & Brubaker, R. R. (1994). Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 62, 4192-4201.
33. O'Gaora, P., Maskell, D., Coleman, D., Cafferkey, M. & Dougan, G. (1989). Cloning and characterization of the serC and aroA genes of Yersinia enterocolitica and construction of an aroA mutant. Gene 84, 23-30.
34. Oyston, P. C. F., Williamson, E. D., Leary, S. E. C., Eley, S. M., Griffin, K. F. & Titball, R. W. (1995). Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect Immun 63, 563-568.
35. Reed, L. J. & Muench, H. (1938). A simple method for estimating fifty percent endpoints. Am J Hyg 27, 493-497.
36. Reisman, R. E. (1907). Allergic reactions due to plague vaccine. J Allergy 46, 49-55.
37. Roberts, M., Maskell, D., Novotony, P. & Dougan, G. (1990). Construction and characterization in vivo of Bordetella pertussis aroA mutants. Infect Immun 58, 732-739.
38. Russell, P., Eley, S. M., Hibbs, S. E., Manchee, R. J., Stagg, A. J. & Titball, R. W. (1995). A comparison of plague vaccine U.S.P. and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13, 1551-1556,
39. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
40. Sigwart, D. F., Stocker, B. A. D. & Clements, J. D. (1989). Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors. Infect Immun 57, 1858-1861.
41. 2+ in Yersinia pestis include structural genes for outer membrane proteins. Inject Immun 51, 445-454.
42. Straley, S. C. & Perry, R. D. (1995). Environmental modulation of gene expression and pathogenesis in Yersinia. Trends Microbiol 3, 310-317.
43. Vaughan, L. M., Smith, P. R. & Foster, T. J. (1993). An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis. Infect Immun 61, 2172-2181.